NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.
about
NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@en
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@nl
type
label
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@en
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@nl
prefLabel
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@en
NRAS and EPHB6 mutation rates ...... s South Island of New Zealand.
@nl
P2093
P2860
P356
P1433
P1476
NRAS and EPHB6 mutation rates ...... us South Island of New Zealand
@en
P2093
Angela M Jones
Antonio Ahn
Diane Kenwright
Jacqui Gardner
Makhdoom Sarwar
Michael R Eccles
Patrick Emanuel
Peter R Shepherd
Serena Rooker
Tim Sutton
P2860
P304
41017-41030
P356
10.18632/ONCOTARGET.9351
P407
P577
2016-07-01T00:00:00Z